Curefini Cream
NDC Package 79974-203-06

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Curefini (petrolatum) cream is apply daily over the affected area, with soft massages to ease absorption. This formulation utilizes a cream delivery system. Marketed by Miramar Cosmetics, Inc Dba Miramar Lab, this product is identified by NDC 79974-203 and is authorized under FDA application M016.

Identification & Billing

NDC Package Code
79974-203-06
Package Description
177.441 mL in 1 TUBE
Product Code
79974-203
11-Digit Billing Format
79974020306
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Curefini
Non-Proprietary Name
Petrolatum
Substance Name
Petrolatum
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
PETROLATUM 300 mg/mL
Usage Information
Apply daily over the affected area, with soft massages to ease absorption. Repeat application as many times as needed to keep skin permanently moisturized.

Regulatory & Marketing

Labeler Name
Miramar Cosmetics, Inc Dba Miramar Lab
Product Type
Human Otc Drug
FDA Application #
M016
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
04-24-2023
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (79974-203). Click a package code to view its specific billing and regulatory data.

79974-203-02
59.147 mL in 1 TUBE
79974-203-04
118.294 mL in 1 TUBE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 79974-203-06 identifies a specific commercial package of 177.441 ml in 1 tube of Curefini, a human over the counter drug labeled by Miramar Cosmetics, Inc Dba Miramar Lab. This cream is formulated for topical use and contains petrolatum as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Miramar Cosmetics, Inc Dba Miramar Lab on April 24, 2023. The current certification is valid through December 31, 2026.

How is this Miramar Cosmetics, Inc Dba Miramar Lab product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 79974020306. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
79974-203-06
11-Digit CMS (5-4-2)
79974-0203-06

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.